바로가기메뉴

본문 바로가기 주메뉴 바로가기

원발성 폐암에서 LKB1 단백질 발현 소실에 따른 임상 양상 및 조직병리학적 특성

The Clinical and Histopathologic Features according to Loss of LKB1 Protein Expression on Primary Lung Cancer

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.64 no.5, pp.362-368
황기은 (원광의대)
이강규 (원광대학교)
박성훈 (원광대학교)
김휘정 (원광대학교)
김학렬 (원광대학교)
양세훈 (원광대학교)
박정현 (원광대학교)
정은택 (원광대학교)
조향정 (원광대학교)
심혁 (원광의대)
송정섭 (원광의대)
신정현 (원광의대)
신성남 (원광의대)
홍경만 (원광의대)
정종훈 (원광의대)
  • 다운로드 수
  • 조회수

초록

연구배경: LKB1 (STK11)유전자는 Peutz-Jeghers syn-drome에서 생식세포 돌연변이가 있으면 소화기와 폐를 포함한 타 장기의 암 발생 위험도가 증가한다고 알려져 있으며, 또한 종양 억제 기능이 있다고도 알려지고 있다. 하지만 현재까지 폐암에서 LKB1 유전자의 생물학적 기능이 명확하게 밝혀져 있지 않아, 저자들은 폐암조직에서 LKB1 단백질 발현소실과 임상양상 및 조직병리와의 연관관계를 알아보고자 하였다. 방 법: 1998년 3월부터 2006년 3월까지 본원에 내원하여 원발성 폐암으로 진단받고 근치적 절제술을 시행 받은 7명의 환자를 대상으로 하였다. 파라핀에 포매된 조직을 택하여 면역조직화학염색법으로 LKB1 단백질 발현을 확인하였고, 정상 기관지 상피세포 세포질에서의 단백질 발현과 비슷한 정도의 발색을 갖는 종양세포가 전체 종양에서 30% 이상인 경우를 양성으로 판정하였다. 결 과: LKB1 발현 양성은 40% (31/77)였고, 남성, 흡연, 편평상피암인 경우에 LKB1 발현 음성률이 통계적으로 유의하게 높았다. 종양위치가 중앙부위일수록 LKB1 발현 음성률이 증가하는 경향이 있으며, 종양 위치가 말초부위인 경우 흡연력이 있는 군에서 LKB1 발현 음성률이 통계적으로 유의하게 높았다. TNM 병기가 진행할수록 LKB1 발현 음성률이 증가하는 경향이 있었으며, T2 병기 이상, N 병기가 진행할수록 LKB1 발현 음성률이 높아지는 경향이 있었으나, 통계적 유의성은 보이지 않았다.

keywords
LKB1, Gender, Smoking, Lung cancer

Abstract

Background: LKB1(STK11) is a serine/threonine kinase that functions as a tumor growth suppressor. The functions of LKB1 in lung cancer are not completely understood. This study evaluated the relationship between LKB1 protein expression and the clinicopathological features in lung cancer tissues. Methods: The expression of LKB1 was studied in paraffin-embedded tumor blocks, which were obtained from 77 patients who had undergone surgery at Wonkwang University Hospital. The expression of the LKB1 protein was considered positive if the staining intensity in the tumor tissue adjacent to the normal airway epithelium was >30%. Results: The LKB1 expression was positive in 31 (40%) of samples. Loss of LKB1 expression was significantly associated with being male, smoking history, and squamous cell carcinoma. In the peripheral sites, the loss of LKB1 expression was strongly associated with a smoking history. A loss of LKB1 expression was more frequently associated with progression according to TNM staging, particularly more than T2, N progression. Conclusion: There was a significant relationship between the loss of the LKB1 protein and gender, smoking history, and histological type in primary lung cancer. Although LKB1 expression was not found to be a significant prognostic factor, further studies with a larger cohort of patient's lung cancer tissue samples will be needed to confirm this.

keywords
LKB1, Gender, Smoking, Lung cancer

참고문헌

1.

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.

2.

2. Minna JD, Ginsberg RJ, Ihde DC. Chapter 30. Cancer of lung. In: DeVita VT, Hellman S, Rosenberg SA,editors. Cancer: principles and practice of oncology.5th ed. Philadelphia: Lippincott-Raven Pub.; 1997. p.849.

3.

3. Hemminki A, Markie D, Tomlinson I, Avizienyte E,Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature1998;391:184-7.

4.

4. Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM,McDonnell SK, Burgart LJ, et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 1998;128:896-9.

5.

5. Ghaffar H, Sahin F, Sanchez-Cepedes M, Su GH,Zahurak M, Sidransky D, et al. LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res 2003;9:2998-3003.

6.

6. Cox G, Jones JL, Andi A, Waller DA, O'Byrne KJ. A biological staging model for operable non-small cell lung cancer. Thorax 2001;56:561-6.

7.

7. Diez M, Pollán M, Maestro M, Torres A, Ortega D,Gómez A, et al. Prediction of recurrence by quantification of p185neu protein in non-small cell lung cancer tissue. Br J Cancer 1997;75:684-9.

8.

8. Hemminki A, Tomlinson I, Markie D, Järvinen H,Sistonen P, Björkqvist AM, et al. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997;15:87-90.

9.

9. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S,Jeschke R, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43.

10.

10. Tiainen M, Ylikorkala A, Makela TP. Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest.Proc Natl Acad Sci USA 1999;96:9248-51.

11.

11. Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res 2002;8:2085-90.

12.

12. Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H,Shaw R, et al. The Peutz–Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell2001;7:1307-19.

13.

13. Avizienyte E, Loukola A, Roth S, Hemminki A,Tarkkanen M, Salovaara R, et al. LKB1 somatic mutations in sporadic tumors. Am J Pathol 1999;154:677-81.

14.

14. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K,Kozlowski P, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007;448:807-10.

15.

15. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S,Trink B, Engles JM, et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.Cancer Res 2002;62:3659-62.

16.

16. Onozato R, Kosaka T, Achiwa H, Kuwano H, Takahashi T, Yatabe Y, et al. LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci 2007;98:1747-51.

17.

17. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking.Int J Cancer 1994;59:494-504.

18.

18. Fraumeni JF JR, Schottenfeld D, Searle JG. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996.

19.

19. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L, et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.Cancer Res 2001;61:1309-13.

Tuberculosis & Respiratory Diseases